Hospital contacts due to hepatobiliary adverse events in >5000 patients with inflammatory joint disease treated with originator or biosimilar etanercept (SB4): an observational nationwide study applying linkage between DANBIO and national registries.
Bente GlintborgStylianos GeorgiadisAnne Gitte LoftAsta LinauskasHanne LindegaardOliver HendricksDorte V JensenBirgitte Lange AndersenKamilla DanebodAnders VillumsenGrith EngCharlotte WiellNatalia ManiloSalome KristensenJohnny RaunJolanta GrydehøjStavros ChrysidisMette NørgaardFrank MehnertNiels Steen KroghMerete Lund HetlandPublished in: Annals of the rheumatic diseases (2020)